Modern Possibilities of Immunoprophylaxis of Prolonged Course of Community-Acquired Pneumonia in Children

Authors

  • Furkat Mukhitdinovich Shamsiev Republican specialized scientific and practical medical center of pediatrics of the ministry of health of the republic of Uzbekistan, Tashkent, Uzbekistan
  • Nilufar Irgashevna Karimova 1Republican specialized scientific and practical medical center of pediatrics of the ministry of health of the republic of Uzbekistan, Tashkent, Uzbekistan
  • Safura Nosirjonovna Zaynabitdinova Andijan state medical institute, Andijan, Uzbekistan

DOI:

https://doi.org/10.48112/acmr.v3i3.37

Keywords:

Children, Community-Acquired Pneumonia of Prolonged Course, Clinic, Immunology

Abstract

Abstract Views: 138

The aim of the study was to develop methods for the prevention of prolonged community-acquired pneumonia in children. 180 children aged 6 months to 15 years with community-acquired pneumonia of a prolonged course, who are being treated in the department of pulmonology, were examined. Analysis of anamnestic data showed that all children, regardless of the development of the disease, had repeatedly suffered acute respiratory infections, pneumonia, intestinal infections, purulent-septic diseases, characterized by a long, recurrent course and difficult to respond to antimicrobial therapy.

References

Chervinets VM, Chervinets IuV, Mikhaĭlova ES, Samoukina AM, Beliaeva EA, Mironov AIu. The microbiocenosis of intestine and immune status of children of primary school age. Klin Lab Diagn. 2013;(1):49-51.

Ferreira-Coimbra J, Sarda C, Rello J. Burden of Community Acquired Pneumonia and Unmet Clinical Needs. Adv Ther. 2020;37(4):1302-1318. doi: 10.1007/s12325-020-01248-7.

Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355-367. doi: 10.1038/s41579-018-0001-8.

Vangay P, Ward T, Gerber JS, Knights D. Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe. 2015;17(5):553-64. doi: 10.1016/j.chom.2015.04.006.

Davies HD. Community-acquired pneumonia in children. Paediatr Child Health. 2003;8(10):616-9. doi: 10.1093/pch/8.10.616.

Smith DK, Kuckel DP, Recidoro AM. Community-Acquired Pneumonia in Children: Rapid Evidence Review. Am Fam Physician. 2021;104(6):618-625.

Walter JM. Other Respiratory Viruses as a Cause of Community-Acquired Pneumonia. Semin Respir Crit Care Med. 2020;41(4):579-591. doi: 10.1055/s-0040-1710537.

Zhestkov AV, Zolotov MO, Lyamin AV, Borisova OV, Chernova OE, Zheleznova EA, et al. Results of immunoprophylaxis of HIV-infected patients with 13-valent conjugated pneumococcal vaccine. Terapevticheskii arkhiv. 2021;93(11):1300-5.

Sahni M, Bhandari V. Patho-mechanisms of the origins of bronchopulmonary dysplasia. Mol Cell Pediatr. 2021;8(1):21. doi: 10.1186/s40348-021-00129-5.

Celik K, Olukman O, Demirol H, Terek D, Gulfidan G, Devrim I, et al. Prevalence of respiratory pathogens during two consecutive respiratory syncytial virus seasons at a tertiary medical care center. Arch Argent Pediatr. 2019;117(4):e356-e362. English, Spanish. doi: 10.5546/aap.2019.eng.e356.

Advances in Clinical Medical Research

Downloads

Published

2022-09-30

How to Cite

Shamsiev, F. M., Karimova, N. I., & Zaynabitdinova, S. N. (2022). Modern Possibilities of Immunoprophylaxis of Prolonged Course of Community-Acquired Pneumonia in Children. Advances in Clinical Medical Research, 3(3), 09–11. https://doi.org/10.48112/acmr.v3i3.37

Issue

Vol. 3 No. 3 (2022): July-September 2022

Section

Articles

License

Copyright (c) 2022 Advances in Clinical Medical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC